Mary C. Choksi
Known title: DirectorCIK: 0001205706
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
White Mountains Upgraded by Analyst Amid Recent Trading Activity. A rating upgrade for White Mountains Insurance Group was issued, moving the stock to a Buy designation from the prior rating. The upgrade reflects renewed analyst confidence in the company's outlook. The stock is currently trading well above its identified support level of $2160.43, suggesting recent price action has already strengthened from recent lows. With a trailing P/E of 4.9, the valuation remains low relative to broader market averages.
Transaction History
| OMC | ▲ Buy | Grant | 696 | $0 | 10/1/2026 | View on chart |
| OMC | ▲ Buy | Grant | 704 | $0 | 7/1/2026 | View on chart |
| WTM | ▲ Buy | Grant | 135 | $0 | 5/21/2026 | View on chart |
| OMC | ▲ Buy | Grant | 681 | $0 | 4/1/2026 | View on chart |
| OMC | ▲ Buy | Grant | 635 | $0 | 1/1/2026 | View on chart |
| OMC | ▲ Buy | Grant | 629 | $0 | 10/1/2025 | View on chart |
| OMC | ▲ Buy | Grant | 712 | $0 | 7/1/2025 | View on chart |
| WTM | ▲ Buy | Grant | 150 | $0 | 5/22/2025 | View on chart |
| OMC | ▲ Buy | Grant | 618 | $0 | 4/1/2025 | View on chart |
| OMC | ▲ Buy | Grant | 596 | $0 | 1/1/2025 | View on chart |
| OMC | ▲ Buy | Grant | 423 | $0 | 10/1/2024 | View on chart |
| OMC | ▲ Buy | Grant | 488 | $0 | 7/1/2024 | View on chart |
| WTM | ▲ Buy | Grant | 165 | $0 | 5/23/2024 | View on chart |
| OMC | ▲ Buy | Grant | 452 | $0 | 4/1/2024 | View on chart |
| OMC | ▲ Buy | Grant | 506 | $0 | 1/1/2024 | View on chart |
| OMC | ▲ Buy | Grant | 587 | $0 | 10/1/2023 | View on chart |
| OMC | ▲ Buy | Grant | 460 | $0 | 7/1/2023 | View on chart |
| WTM | ▲ Buy | Grant | 180 | $0 | 5/25/2023 | View on chart |
| OMC | ▲ Buy | Grant | 464 | $0 | 4/1/2023 | View on chart |
| OMC | ▲ Buy | Grant | 536 | $0 | 1/1/2023 | View on chart |
| OMC | ▲ Buy | Grant | 693 | $0 | 10/1/2022 | View on chart |
| OMC | ▲ Buy | Grant | 688 | $0 | 7/1/2022 | View on chart |
| WTM | ▲ Buy | Grant | 225 | $0 | 5/26/2022 | View on chart |
| OMC | ▲ Buy | Grant | 515 | $0 | 4/1/2022 | View on chart |
| OMC | ▲ Buy | Grant | 597 | $0 | 1/1/2022 | View on chart |
| OMC | ▲ Buy | Grant | 604 | $0 | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Omnicom Announces Q3 2026 Earnings Call and Highlights AI Strategy
Omnicom Group has set a date for its third‑quarter 2026 earnings release and conference call, signaling a new reporting cycle. The company’s leadership, including CEO Christine Gambino and CFO Ben Hovaness, has emphasized the importance of AI and data for unified brand responses. Analysts note that the firm may be undervalued by about 23% following the finance leadership change, and its cash‑flow value suggests a reasonable stock price. These developments suggest a focus on technology and financial positioning as Omnicom prepares for the upcoming earnings.
Omnicom Announces Q3 2026 Earnings Call and Highlights AI Strategy. Omnicom Group has set a date for its third‑quarter 2026 earnings release and conference call, signaling a new reporting cycle. The company’s leadership, including CEO Christine Gambino and CFO Ben Hovaness, has emphasized the importance of AI and data for unified brand responses. Analysts note that the firm may be undervalued by about 23% following the finance leadership change, and its cash‑flow value suggests a reasonable stock price. These developments suggest a focus on technology and financial positioning as Omnicom prepares for the upcoming earnings.